182 related articles for article (PubMed ID: 15256718)
1. Pharmacogenomics of drug transporters: a new approach to functional analysis of the genetic polymorphisms of ABCB1 (P-glycoprotein/MDR1).
Ishikawa T; Onishi Y; Hirano H; Oosumi K; Nagakura M; Tarui S
Biol Pharm Bull; 2004 Jul; 27(7):939-48. PubMed ID: 15256718
[TBL] [Abstract][Full Text] [Related]
2. Functional evaluation of ABCB1 (P-glycoprotein) polymorphisms: high-speed screening and structure-activity relationship analyses.
Ishikawa T; Hirano H; Onishi Y; Sakurai A; Tarui S
Drug Metab Pharmacokinet; 2004 Feb; 19(1):1-14. PubMed ID: 15499164
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition.
Haufroid V
Curr Drug Targets; 2011 May; 12(5):631-46. PubMed ID: 21039333
[TBL] [Abstract][Full Text] [Related]
4. Emerging new technologies in Pharmacogenomics: rapid SNP detection, molecular dynamic simulation, and QSAR analysis methods to validate clinically important genetic variants of human ABC Transporter ABCB1 (P-gp/MDR1).
Ishikawa T; Sakurai A; Hirano H; Lezhava A; Sakurai M; Hayashizaki Y
Pharmacol Ther; 2010 Apr; 126(1):69-81. PubMed ID: 20138191
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCG2: therapeutic implications.
Sakurai A; Tamura A; Onishi Y; Ishikawa T
Expert Opin Pharmacother; 2005 Nov; 6(14):2455-73. PubMed ID: 16259577
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of drug transporters and its impact on the pharmacotherapy.
Sakaeda T; Nakamura T; Okumura K
Curr Top Med Chem; 2004; 4(13):1385-98. PubMed ID: 15379652
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.
Uhr M; Tontsch A; Namendorf C; Ripke S; Lucae S; Ising M; Dose T; Ebinger M; Rosenhagen M; Kohli M; Kloiber S; Salyakina D; Bettecken T; Specht M; Pütz B; Binder EB; Müller-Myhsok B; Holsboer F
Neuron; 2008 Jan; 57(2):203-9. PubMed ID: 18215618
[TBL] [Abstract][Full Text] [Related]
8. Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs.
Maeda K; Sugiyama Y
Drug Metab Pharmacokinet; 2008; 23(4):223-35. PubMed ID: 18762709
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response.
Wada M
Cancer Lett; 2006 Mar; 234(1):40-50. PubMed ID: 16377077
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of drug transporters in the enterohepatic circulation.
Stieger B; Meier PJ
Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
[TBL] [Abstract][Full Text] [Related]
11. How to make P-glycoprotein (ABCB1, MDR1) harbor mutations and measure its expression and activity in cell cultures?
Zubiaur P; Saiz-Rodríguez M; Koller D; Ovejero-Benito MC; Wojnicz A; Abad-Santos F
Pharmacogenomics; 2018 Nov; 19(16):1285-1297. PubMed ID: 30334473
[TBL] [Abstract][Full Text] [Related]
12. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
[TBL] [Abstract][Full Text] [Related]
13. The clinical impact of ABCB1 polymorphisms on the treatment of psychiatric diseases.
Rosenhagen MC; Uhr M
Curr Pharm Des; 2011; 17(26):2843-51. PubMed ID: 21827404
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics: the influence of genomic variation on drug response.
Thomas FJ; McLeod HL; Watters JW
Curr Top Med Chem; 2004; 4(13):1399-409. PubMed ID: 15379653
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein mechanical functional analysis using in silico molecular modeling: Pharmacokinetic variability according to ABCB1 c.2677G > T/A genetic polymorphisms.
Jeong SH; Jang JH; Lee YB
Int J Biol Macromol; 2023 Sep; 249():126777. PubMed ID: 37683742
[TBL] [Abstract][Full Text] [Related]
16. ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression.
Sarginson JE; Lazzeroni LC; Ryan HS; Ershoff BD; Schatzberg AF; Murphy GM
Pharmacogenet Genomics; 2010 Aug; 20(8):467-75. PubMed ID: 20555295
[TBL] [Abstract][Full Text] [Related]
17. Inter-individual variations and modulators of MDR1 transport activity in human placenta.
Wang X; Song Y; Wu D; Li Q; Lu S; Li X; Huang H; Zhang J
Placenta; 2020 Aug; 97():46-50. PubMed ID: 32792062
[TBL] [Abstract][Full Text] [Related]
18. Drug delivery to the brain: considerations of genetic polymorphisms of blood-brain barrier transporters and imaging technologies.
Bai JP
Ther Deliv; 2010 Oct; 1(4):563-70. PubMed ID: 22833967
[TBL] [Abstract][Full Text] [Related]
19. Promoter Haplotypes of the ABCB1 Gene Encoding the P-Glycoprotein Differentially Affect Its Promoter Activity by Altering Transcription Factor Binding.
Speidel JT; Xu M; Abdel-Rahman SZ
DNA Cell Biol; 2018 Dec; 37(12):973-981. PubMed ID: 30277801
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.
Ahmed S; Zhou Z; Zhou J; Chen SQ
Genomics Proteomics Bioinformatics; 2016 Oct; 14(5):298-313. PubMed ID: 27729266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
